0001826834-21-000002.txt : 20211220 0001826834-21-000002.hdr.sgml : 20211220 20211220155822 ACCESSION NUMBER: 0001826834-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211220 DATE AS OF CHANGE: 20211220 EFFECTIVENESS DATE: 20211220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biopharmaceutical Research Co CENTRAL INDEX KEY: 0001826834 IRS NUMBER: 820650107 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-425934 FILM NUMBER: 211505182 BUSINESS ADDRESS: STREET 1: 11045 COMMERCIAL PARKWAY CITY: CASTROVILLE STATE: CA ZIP: 95012 BUSINESS PHONE: 831-632-0913 MAIL ADDRESS: STREET 1: 11045 COMMERCIAL PARKWAY CITY: CASTROVILLE STATE: CA ZIP: 95012 D 1 primary_doc.xml X0708 D LIVE 0001826834 Biopharmaceutical Research Co 11045 COMMERCIAL PARKWAY CASTROVILLE CA CALIFORNIA 95012 831-632-0913 DELAWARE Biopharmaceutical Research Company, LLC None Corporation true 2017 George Hodgin 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Executive Officer Director Charles Schumacher 11045 Commercial Parkway Castroville CA CALIFORNIA 95012 Director Other Technology Decline to Disclose 06b false 2021-12-10 false true true true false 0 85876 85876 0 false 1 0 0 0 The warrant is being issued in full satisfaction of the Issuer's obligation to North Point Advisors Inc. for advisory services in connection with the Issuer's Equity Private Placement. false Biopharmaceutical Research Co /s/ George Hodgin George Hodgin Chief Executive Officer 2021-12-20